top of page
Browse by category
Search


EndoQuest reveals first ELS endobariatrics post-bypass gastric reconstruction procedure
EndoQuest Robotics has announced the successful completion of two robotic transoral gastric reconstruction procedures using the company’s Endoluminal Surgical (ELS) System. Building on the established clinical framework of transoral outlet reduction (TORe), this fully robotic approach uses two-handed instrumentation to precisely perform full-thickness suturing, bringing surgical dexterity and control to post-bypass gastric reconstruction entirely through the mouth. Endolumina


Effective obesity treatments reach few eligible teens
Despite the arrival of powerful new anti-obesity medications and growing evidence supporting weight-loss surgery for adolescents, the vast majority of eligible teens are receiving neither treatment, according to a Northwestern Medicine study. “The motivation behind our paper in JAMA Pediatrics was to look at the relationship between two exciting developments in the treatment of obesity and adolescence,” said first author, Dr John B Rode, a fourth-year resident physician at An


Surgery effective for substantial weight loss after GLP-1 intolerance or limited weight loss
A Cleveland Clinic study has found that people with obesity who do not tolerate the weight-loss medications semaglutide or tirzepatide, or who do not lose enough weight with the medications, can achieve substantial weight loss after bariatric surgery. Ali Aminian (Credit: Cleveland Clinic) “GLP-1 medications have transformed obesity care, but they don’t work for everyone,” said Dr Ali Aminian, director of Cleveland Clinic’s Bariatric and Metabolic Institute, and lead author o


ŌURA establishes clinical trial to examine how Oura Ring data relate to outcomes from GLP-1 and MBS
ŌURA has announced the launch of SMART-BMI, its first clinical trial, in collaboration with UC San Diego Health, that will examine how sleep, heart rate, and activity data from Oura Ring relate to outcomes from GLP-1 treatment and bariatric surgery. The multi-year study is the latest addition to Oura’s growing work in healthcare research, scientific validation, and outcomes measurement, led by the Office of Regulatory and Clinical Affairs (ORCA), which was built over the past


Boehringer Ingelheim establishes Metabolic Matters Steering Committee for obesity and related liver diseases
Boehringer Ingelheim has formed the Metabolic Matters Steering Committee, a multidisciplinary effort focused on advancing outcomes for conditions, such as obesity, that impact metabolic health. The Committee is comprised of leading clinicians, advocates and experts who have committed to identifying opportunities to close gaps in diagnosis and care, improve patient-provider dialogue, and advance public understanding of metabolic health. Obesity and other cardiometabolic condit


GLP-1 drugs help patients lose regained weight after bariatric surgery
People who regain weight after bariatric surgery may benefit from glucagon-like peptide-1 receptor agonists (GLP-1s), according to a study involving Regenstrief Institute, Indiana University, Purdue University and University of Florida researchers. The study found that patients prescribed these medications lost more of their regained weight over six and 12 months than comparable patients who did not use them. Bariatric surgery can produce substantial weight loss, but some pat
Browse by tag






bottom of page
